Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Prostatic Neoplasms 1Lung Neoplasms 1Diarrhea 1

Interventions

Irinotecan 3Theophylline 1Temozolomide 1Oxaliplatin 1Loperamide 1Leucovorin 1Fluorouracil 1Fecal Microbiota Transplantation 1Erlotinib Hydrochloride 1Celecoxib 1Cefpodoxime 1Cefixime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Diarrhea × Theophylline × Clear all
NCT02080078 2019-05-03

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

AHS Cancer Control Alberta

Phase 1 Terminated
15 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡